Telecardia is a Boston-based technology development company that builds MEMS-enabled pH sensing platforms. Its AccuMET product line includes a Single Measurement Chip (SMC) for discrete measurements and a Multiple Measurement Chip (MMC). The company also offers a Continuous Self-Calibrating chip (CSC) for continuous monitoring and a CSCxt designed for long-term continuous monitoring (10 years or more). Telecardia describes its platforms as disruptive, proprietary, and versatile. The article does not disclose operating metrics or revenue.

Total raised

$2M

Funding rounds

1

Latest round

Equity

Latest activity

Sep 2011